Surf1- Related Severe Demyelinating Charcot-Marie-Tooth (CMT) Disease

Surf1-related severe demyelinating Charcot-Marie-Tooth (CMT) disease is a very rare inherited nerve disease. It mainly damages the long nerves that go from the spinal cord to the feet and hands. These nerves help you move your muscles and feel touch, pain, and temperature. When they are damaged, signals travel more slowly or get lost, so the muscles become weak and feeling becomes poor. NCBI+2NCBI+2

SURF1-related severe demyelinating Charcot-Marie-Tooth (CMT) disease is a rare genetic nerve disease. The SURF1 gene helps mitochondria, the “power stations” inside cells, work properly. When SURF1 does not work, the cells in the nervous system do not make enough energy. The myelin sheath, the fatty coating around nerves, becomes damaged (demyelination). This slows or blocks nerve signals. Over time, people can have weak muscles, balance problems, numbness, and deformity in the feet and hands. It usually begins in childhood. There is no cure yet, but many treatments can support movement, reduce symptoms, and protect quality of life.

In most types of CMT, the outside “insulation layer” of the nerve, called myelin, is damaged. This is called a demyelinating neuropathy. Myelin acts like the plastic coating around an electric wire. When myelin is damaged, the nerve signals slow down a lot. In demyelinating CMT, nerve conduction studies show very slow signal speeds. NCBI+2ScienceDirect+2

In this special form, the disease is caused by harmful changes (mutations) in a gene called SURF1. The SURF1 gene tells the body how to make a protein that sits in the inner membrane of mitochondria (the “power stations” inside cells). This protein helps build complex IV (cytochrome c oxidase), an important part of the energy-making chain called oxidative phosphorylation. When SURF1 does not work, complex IV does not form well, and cells cannot make enough energy. JBC+3MedlinePlus+3ScienceDirect+3

Usually, SURF1 mutations cause a brain disorder called Leigh syndrome. In a few families, however, SURF1 mutations mainly cause a severe demyelinating neuropathy that looks like a recessive form of CMT (similar to CMT4). In these patients, nerve conduction is very slow and nerve biopsies show loss of myelin. ResearchGate+3PMC+3ScienceDirect+3

---

Other names

Doctors may use several names for this condition. All of them point to the same basic problem: a demyelinating hereditary neuropathy caused by SURF1 mutations and complex IV (cytochrome-c-oxidase) deficiency in mitochondria. PMC+2ScienceDirect+2

Some names you may see:

• SURF1-related Charcot-Marie-Tooth disease

• SURF1-deficiency demyelinating neuropathy

• Recessive demyelinating CMT associated with SURF1 mutation

• Mitochondrial complex IV–related CMT

• SURF1-related hereditary motor and sensory neuropathy (HMSN)

These names may appear in case reports and genetic lab reports. The exact label can differ between hospitals, but the underlying problem is the same: SURF1 mutations causing severe nerve demyelination. PMC+2ResearchGate+2

---

Types (clinical patterns)

Because there are only a few reported families, there is not a strict official “type list” like CMT1A or CMT2A. But doctors do notice different patterns in people with SURF1-related demyelinating CMT. These patterns can be thought of as clinical “types.” PMC+2ScienceDirect+2

• Type 1 – Mainly peripheral nerve type
  In this pattern, problems mostly affect the peripheral nerves. The main signs are weakness in the feet and hands, foot deformities, loss of feeling, and very slow nerve conduction on tests. Brain scans may be nearly normal, and thinking and speech may be only mildly affected or normal. PMC+2NCBI+2

• Type 2 – Mixed neuropathy and brain involvement type
  Some patients have both severe peripheral neuropathy and brain involvement similar to Leigh syndrome. They may have muscle weakness, loss of balance, and also problems like developmental delay, abnormal eye movements, or breathing difficulties. MRI of the brain may show “Lesions” in deep brain areas where energy demand is high. PMC+2PubMed+2

• Type 3 – Early-infantile severe type
  In this pattern, symptoms start very early in life. Babies may have weak muscle tone (floppiness), feeding problems, delayed milestones, and early foot weakness. They may later develop typical CMT signs plus features of mitochondrial disease, such as high lactate in blood or spinal fluid. PMC+2PubMed+2

These “types” are based on how the disease looks in real patients. They are not separate genetic diseases, but different ways the same SURF1 problem can show itself in the body. NCBI+2ScienceDirect+2

---

Causes

All causes are linked to one core problem: SURF1 mutation → complex IV defect → low energy in nerve cells → demyelination and nerve damage. MedlinePlus+2ScienceDirect+2

1. Pathogenic SURF1 gene mutation
   The main cause is a harmful change in both copies of the SURF1 gene. This change makes the SURF1 protein faulty or missing. Without normal SURF1, complex IV in mitochondria does not assemble correctly, and cells cannot use oxygen well to make energy. MedlinePlus+1

2. Autosomal recessive inheritance
   SURF1-related CMT is inherited in an autosomal recessive way. This means the child must receive one faulty SURF1 gene from each parent. The parents usually have one normal and one faulty gene and may have no symptoms or only very mild nerve signs. PMC+1

3. Nonsense mutations in SURF1
   A nonsense mutation creates a “stop” signal in the gene too early. This cuts the protein short, so it cannot help build complex IV. Truncated SURF1 protein is quickly broken down, leaving cells with almost no functional SURF1. PubMed+1

4. Missense mutations in SURF1
   Missense mutations change one amino acid in the protein. Even this small change can distort the protein shape, so it cannot fit properly into the inner mitochondrial membrane or cannot interact with other complex IV parts. This also leads to poor energy production. ScienceDirect+1

5. Splice-site mutations in SURF1
   Some mutations affect the “splicing” signals that tell the cell how to cut and join gene pieces (exons). Wrong splicing creates abnormal SURF1 messenger RNA and an abnormal protein, which again damages complex IV assembly. PubMed+1

6. Frameshift mutations
   When small pieces of DNA are added or removed, the reading frame of the gene shifts. This usually leads to many wrong amino acids and an early stop codon. The resulting SURF1 protein is unstable and non-functional. FEBS Journal+1

7. Loss of SURF1 protein in mitochondria
   Because of these different mutations, the total amount of SURF1 protein in the inner mitochondrial membrane becomes very low. Without SURF1, the cell cannot assemble complex IV correctly, especially in high-energy tissues like brain and peripheral nerves. MedlinePlus+1

8. Defective complex IV (cytochrome c oxidase) assembly
   SURF1 works as a helper (assembly factor) for complex IV. When SURF1 is abnormal, complex IV does not form or work properly. This block in the electron transport chain stops the final step where oxygen is used to make energy. ScienceDirect+2FEBS Journal+2

9. Reduced energy (ATP) supply to Schwann cells
   Schwann cells make and maintain myelin around peripheral nerves. They need a lot of ATP. When complex IV is weak, Schwann cells cannot make enough energy, so myelin maintenance fails and demyelination begins. ScienceDirect+2ScienceDirect+2

10. Energy failure in long peripheral nerves
    The longest nerves, going to the feet, are especially sensitive to energy shortage. They are far from the cell body and need a very efficient energy system. Mitochondrial failure in these nerves leads to early weakness and deformity in the feet and ankles. NCBI+2ScienceDirect+2

11. Oxidative stress in nerve cells
    When the electron transport chain is not working well, more “reactive oxygen species” (ROS) are formed. These molecules damage lipids, proteins, and DNA. In nerves, this oxidative stress further harms myelin and axons. ScienceDirect+2FEBS Journal+2

12. Secondary demyelination
    Because Schwann cells are sick and stressed, they cannot keep the myelin sheaths healthy. Myelin becomes thin, broken, or lost. Nerve conduction velocities drop a lot, which is the hallmark of demyelinating CMT. PMC+2ScienceDirect+2

13. Secondary axonal degeneration
    Over time, poorly myelinated axons begin to shrink and die back from the ends. This leads to permanent muscle wasting and sensory loss, especially in the feet and hands. Once axons are lost, recovery becomes much harder. NCBI+2NCBI+2

14. Other mitochondrial gene variants as modifiers
    Some patients may carry extra changes in other mitochondrial or nuclear genes. These changes do not cause disease alone but can make the SURF1-related disease more severe or start earlier by further lowering mitochondrial function. ScienceDirect+2Dove Medical Press+2

15. Parental consanguinity (related parents)
    When parents are blood relatives (for example, cousins), they share more genes. This increases the chance that a child will inherit two copies of the same rare SURF1 mutation, making SURF1-related CMT more likely in that family. PMC+1

16. Intercurrent infections and fever
    Any illness that raises body temperature or energy demand can stress already weak mitochondria. During fever, nerve symptoms such as weakness or fatigue can temporarily worsen because the energy system is under extra strain. NCBI+2Cleveland Clinic+2

17. Poor nutrition or vitamin deficiency
    Nerves need vitamins (especially B vitamins) and good nutrition for repair and function. In someone with SURF1-related disease, lack of these nutrients may worsen neuropathy, even though it is not the original cause. NCBI+1

18. Delayed diagnosis and lack of supportive care
    If the disease is not recognized early, children may not receive physiotherapy, orthotics, or other supportive treatments. This delay allows contractures, deformities, and muscle wasting to become more severe over time. NCBI+2Cleveland Clinic+2

19. Coexisting nerve-damaging conditions (for example, diabetes)
    If a person with SURF1-related CMT also develops another nerve-damaging disease, such as diabetes, alcohol-related neuropathy, or severe vitamin deficiency, the combined damage will make the neuropathy much worse. NCBI+2ScienceDirect+2

20. Unknown or still-unfound genetic and environmental factors
    Medicine does not yet know all the reasons why some people with the same SURF1 mutation are more severely affected than others. Other genes, lifestyle factors, and random events likely play a role and are still being studied. ScienceDirect+2Dove Medical Press+2

---

Symptoms

Symptoms usually start in childhood or early teenage years. They tend to slowly get worse over time. Many are similar to other demyelinating CMT types, but sometimes they are more severe because of the mitochondrial energy problem. Mayo Clinic+3NCBI+3NCBI+3

1. Weakness in feet and ankles
   The earliest sign is often weakness of the muscles that lift the foot. Children may have trouble standing on their heels or may drag their toes when walking. NCBI+1

2. Difficulty walking and running
   Because of weakness and poor nerve signals, walking can look clumsy or high-stepping. Running becomes hard, and the child may be slower than classmates in sports. NCBI+2Cleveland Clinic+2

3. Frequent tripping and falls
   Foot drop and poor balance mean the toes catch on the ground. This leads to repeated stumbles and falls, especially on uneven ground or in the dark. Cleveland Clinic+1

4. Foot deformities (high arches and hammertoes)
   Over time, imbalance between weak and strong muscles in the foot causes high arches (pes cavus) and curled toes (hammertoes). These deformities can make shoe fitting and walking more difficult. NCBI+2Cleveland Clinic+2

5. Loss of ankle reflexes
   When the neurologist tests the Achilles tendon with a hammer, the normal “jerk” may be very weak or absent. This is a common sign of peripheral neuropathy in CMT, including SURF1-related forms. NCBI+2NCBI+2

6. Numbness or reduced feeling in the feet
   Many patients notice that their feet feel “dull,” “wooden,” or “wrapped in cotton.” They may not feel small injuries or temperature changes well. NCBI+2Cleveland Clinic+2

7. Tingling or burning sensations
   Some people describe pins-and-needles, buzzing, or burning pain in the feet and lower legs. This is neuropathic pain from damaged sensory fibers. NCBI+2Cleveland Clinic+2

8. Muscle wasting in lower legs
   As motor nerves fail, muscles shrink. The calves can become thin, giving a “stork leg” or “inverted champagne bottle” appearance. This is common in advanced CMT. NCBI+2Mayo Clinic+2

9. Weakness in hands and fingers
   Later in the disease, the hands can become weak. Tasks like buttoning clothes, writing, or opening jars may become harder. NCBI+2NCBI+2

10. Poor balance and unsteady gait
    Loss of position sense in the feet and weakness in the legs make balance difficult. People may sway when standing with eyes closed or have a wide-based, unsteady walk. NCBI+2Cleveland Clinic+2

11. Fatigue and low energy
    Because of mitochondrial dysfunction, children and adults with SURF1-related disease may tire more quickly than others. Even small tasks can feel exhausting. ScienceDirect+2PubMed+2

12. Pain in feet or legs
    Some patients have chronic pain due to nerve damage or due to joint and muscle strain from abnormal gait and deformities. Pain can be burning, aching, or cramping. NCBI+1

13. Delay in motor milestones
    Babies and toddlers may sit, stand, or walk later than expected. Caregivers may first notice that the child is slower than peers in motor development. NCBI+2Mayo Clinic+2

14. Breathing or swallowing problems in severe cases
    If the disease has strong mitochondrial brain involvement, some patients can develop weak breathing muscles or difficulty swallowing. This is less common but very serious and needs urgent medical care. PubMed+2JBC+2

15. Spinal curvature (scoliosis)
    Long-term muscle imbalance around the spine can lead to side-to-side curvature (scoliosis). This may cause back pain and worsen breathing in severe cases. NCBI+2Life in the Fast Lane • LITFL+2

---

Diagnostic tests

Doctors use several groups of tests to diagnose SURF1-related severe demyelinating CMT and to rule out other causes. These include physical exam, manual tests, lab/pathology tests, electrodiagnostic tests, and imaging tests. Blueprint Genetics+3NCBI+3NCBI+3

Physical exam tests

1. Complete neurological examination
   The doctor checks muscle strength, tone, reflexes, and sensation in all four limbs. In SURF1-related CMT, they often find weakness and wasting in the feet and hands, reduced or absent reflexes at the ankles, and sensory loss in a “glove and stocking” pattern. NCBI+2NCBI+2

2. Gait and posture observation
   The way a person walks gives important clues. The doctor watches for high-stepping gait, foot drop, wide-based walking, or frequent tripping. They also look at posture, including any spinal curvature or bent knees. NCBI+1

3. Foot and hand inspection
   The doctor carefully looks at the shape of the feet and hands. In CMT, they often see high arches, hammertoes, thin calves, and sometimes clawing of the fingers. Skin color, temperature, and any pressure sores are also checked. NCBI+2Cleveland Clinic+2

4. Reflex testing
   Using a reflex hammer, the doctor tests knee and ankle jerks and sometimes arm reflexes. In demyelinating CMT, reflexes at the ankles are usually very weak or absent, helping distinguish peripheral neuropathy from other movement disorders. NCBI+2NCBI+2

Manual tests

5. Manual muscle strength testing
   The doctor or physiotherapist tests each muscle group by hand and grades the power on a standard scale. This simple test shows which muscles are weak and helps track progression over time. NCBI+2Life in the Fast Lane • LITFL+2

6. Sensory testing (touch, pin, vibration)
   Light touch is tested with cotton, pain with a blunt pin, and vibration with a tuning fork. Loss of these sensations in the feet and hands is typical of hereditary motor and sensory neuropathies like CMT. NCBI+2NCBI+2

7. Balance and Romberg test
   The patient stands with feet together, first with eyes open and then closed. Increased swaying or falling when the eyes are closed suggests poor position sense from damaged sensory nerves. NCBI+2Life in the Fast Lane • LITFL+2

8. Functional hand tests
   Simple tasks such as buttoning a shirt, writing, or picking up small objects test fine motor skills. Difficulty with these tasks shows weakness and sensory loss in the hands. NCBI+2Cleveland Clinic+2

Lab and pathological tests

9. Basic blood tests (general screen)
   Doctors often order routine blood tests to rule out other causes of neuropathy, such as diabetes, kidney disease, vitamin deficiencies, thyroid disease, or severe infections. These tests help confirm that the neuropathy is likely genetic rather than acquired. NCBI+2PFM Journal+2

10. Blood lactate and pyruvate levels
    Because SURF1 mutations affect mitochondrial energy production, lactate and pyruvate in blood or spinal fluid can be raised, especially when there is brain involvement like Leigh syndrome. This supports the presence of a mitochondrial disorder. ScienceDirect+2PubMed+2

11. Targeted SURF1 gene testing
    Once mitochondrial involvement or demyelinating CMT with unusual features is suspected, genetic testing can directly read the SURF1 gene. Finding two disease-causing SURF1 mutations confirms the diagnosis. PMC+2MedlinePlus+2

12. Expanded CMT gene panel or exome sequencing
    If the cause is not clear, doctors may order a larger test that looks at many CMT genes at once, or even most genes in the body (whole exome). This approach often finds rare genes like SURF1 linked to neuropathy. ScienceDirect+2Blueprint Genetics+2

13. Nerve or muscle biopsy with special stains
    In selected cases, a small piece of nerve (often sural nerve) or muscle is taken and studied under the microscope. In SURF1-related disease, nerve biopsy may show loss of myelin and axonal changes, while muscle or nerve staining can show complex IV deficiency in mitochondria. PMC+2ScienceDirect+2

Electrodiagnostic tests

14. Nerve conduction studies (NCS)
    Electrodes are placed on the skin over nerves in the arms and legs. Small electrical pulses are used to measure how fast and how strongly signals travel. In demyelinating CMT, conduction velocities are very slow, showing that myelin is damaged. Life in the Fast Lane • LITFL+3NCBI+3NCBI+3

15. Electromyography (EMG)
    A fine needle electrode is inserted into muscles to record their electrical activity. EMG in CMT shows changes consistent with chronic denervation and re-innervation, confirming that the muscle problem comes from nerve damage. NCBI+2ScienceDirect+2

16. F-wave and H-reflex studies
    These special parts of nerve conduction testing look at how signals travel back and forth along the whole length of a nerve and spinal reflex arc. They are often abnormal in demyelinating neuropathies and add evidence that long motor pathways are affected. ScienceDirect+2Life in the Fast Lane • LITFL+2

17. Somatosensory evoked potentials (SSEPs)
    Small electrical or sensory stimuli are applied to the skin, and responses are recorded along the spinal cord and brain. Abnormal SSEPs can show slowed signal conduction in sensory pathways and may suggest combined peripheral and central involvement. ScienceDirect+2PFM Journal+2

Imaging tests

18. Brain MRI
    MRI of the brain can show typical Leigh-like lesions in deep brain structures in some SURF1-related patients. These are areas where energy demand is high and mitochondria are especially stressed. MRI helps confirm mitochondrial involvement and rule out other brain diseases. PubMed+2JBC+2

19. Spinal MRI
    MRI of the spinal cord and roots helps exclude other causes of weakness, such as spinal cord compression or inflammation. In pure CMT, the spinal cord is usually normal, supporting a peripheral nerve cause. NCBI+2Life in the Fast Lane • LITFL+2

20. X-rays or other imaging of feet and legs
    Simple X-rays can show bone changes and deformities such as high arches, hammertoes, or ankle misalignment. These images help surgeons and orthopedists plan braces or corrective surgery when needed. NCBI+2Cleveland Clinic+2

Non-pharmacological treatments (therapies and other supports)

Below are key non-drug treatments that are widely used in CMT and mitochondrial disease care.

Always work with a neuromuscular team (neurologist, physiotherapist, occupational therapist, orthopaedic surgeon, respiratory specialist, dietitian, psychologist).

1. Individualised physiotherapy program
   Regular physiotherapy using gentle, low-impact exercises helps keep muscles flexible and as strong as possible. A therapist will design stretching, strengthening, and balance exercises that match the person’s weakness pattern and fatigue level. This can delay contractures (fixed tight joints), improve walking, and reduce falls. For CMT, strengthening and aerobic exercise have been shown to support function when done carefully and not to exhaustion.nhs.uk+2PubMed+2

2. Low-impact aerobic exercise
   Activities like swimming, cycling, or walking in short bouts can improve heart fitness and endurance without pounding weak joints. Experts in CMT usually advise low-impact exercise because ankle and knee joints are already stressed by deformity and muscle imbalance. Aerobic exercise also helps with weight control, mood, and sleep, which indirectly supports nerve and muscle health.nhs.uk+2Muscular Dystrophy Association+2

3. Stretching and contracture prevention
   Daily gentle stretching of ankles, calves, hips, wrists, and fingers can slow down tendon shortening and joint stiffness. In CMT, cavovarus feet and toe deformities are very common if muscles pull unevenly; early stretching plus night splints can delay these changes. Keeping a full range of motion reduces pain and makes later bracing or surgery more successful.nhs.uk+2ENMC+2

4. Ankle-foot orthoses (AFOs) and braces
   Light plastic or carbon-fibre AFOs can lift the foot, reduce “foot-drop,” and improve balance and walking safety. In CMT, these braces are a core part of management when distal weakness is significant, and they may delay the need for surgery. They also reduce energy use for walking, which is especially important in mitochondrial disease, where fatigue is common.ScienceDirect+2orthobullets.com+2

5. Custom footwear and podiatry care
   Special shoes with high heels, wide toe boxes, and good ankle support help fit cavus or deformed feet. Podiatrists can trim calluses, advise on insoles, and monitor pressure points to prevent ulcers, especially if sensation is reduced. Good footwear makes braces more comfortable and reduces falls.ScienceDirect+2Charcot-Marie-Tooth Association+2

6. Occupational therapy for hands and daily tasks
   Occupational therapists help people with hand weakness or numbness use adaptive tools (built-up pens, special cutlery, button hooks) and change their home or school environment. In CMT, OT also teaches joint-protective techniques and energy conservation so people can dress, cook, and study with less pain and fatigue.ScienceDirect+2Charcot-Marie-Tooth Association+2

7. Mobility aids (sticks, walkers, wheelchairs)
   As SURF1-related CMT is often severe and early, many patients need mobility aids while still young. Properly chosen canes, crutches, or rollators can prevent falls and injuries. A wheelchair or scooter may be used for longer distances to save energy; this is not “giving up” but protecting limited strength and mitochondrial reserves.ScienceDirect+2PubMed+2

8. Respiratory monitoring and non-invasive ventilation
   Because mitochondrial disorders can weaken breathing muscles, regular lung function tests and sleep studies are important. If night-time low oxygen or high carbon dioxide appears, bilevel positive airway pressure (BiPAP) or other non-invasive ventilation can support breathing. In rare, advanced cases, tracheostomy and long-term ventilation may be needed, but these can greatly improve comfort and survival.The Open Neurology Journal+2PMC+2

9. Speech and swallowing therapy
   If the disease affects bulbar muscles, patients may have nasal speech, choking, or slow swallowing. Speech-language therapists can teach safer swallowing techniques, texture modification, and positioning, and help maintain communication. Timely assessment can prevent aspiration and weight loss and may guide decisions about feeding tubes if needed.ERS Publications+1

10. Nutritional and metabolic support
    For mitochondrial disorders, dietitians often recommend regular meals, avoiding long fasting, and sometimes higher-energy diets to match increased energy needs. Avoiding dehydration and hypoglycaemia can prevent metabolic crashes. Many guidelines stress small, frequent meals, attention to swallowing problems, and sometimes special formulas or feeding tubes in severe cases.mitoaction.org+2mitocanada.org+2

11. Psychological support and peer groups
    Living with a progressive childhood-onset disease is emotionally hard for patients and families. Counseling, family therapy, and peer support groups for CMT or mitochondrial disease can reduce anxiety and depression and help with coping, school issues, and future planning. Emotional health also improves adherence to exercise, bracing, and medical follow-up.FDA Access Data+2Charcot-Marie-Tooth Association+2

12. Genetic counseling and family planning advice
    SURF1-related CMT is usually autosomal recessive, so each parent is typically a healthy carrier. Genetic counseling helps families understand recurrence risks, options for genetic testing of siblings, and possible prenatal or pre-implantation diagnosis in future pregnancies. Being informed can reduce guilt and uncertainty and support longer-term planning.ZFIN+2Springer+2

13. Fall-prevention and home adaptations
    Simple changes like grab bars, non-slip mats, good lighting, and removing loose rugs can sharply reduce falls. Occupational therapists may suggest stair rails, ramps, raised toilet seats, or shower chairs. This is vital when balance and sensation are poor, and when bone health might be fragile due to low activity or steroids.Charcot-Marie-Tooth Association+2orthobullets.com+2

14. School and workplace accommodations
    Many people with CMT can continue education and work with adjustments such as extra time for writing, computer use instead of handwriting, accessible classrooms, or flexible schedules. Vocational rehabilitation helps find roles that match physical ability and energy. Early planning helps protect independence.Charcot-Marie-Tooth Association+2European CMT Federation+2

15. Pain coping skills and cognitive-behavioural therapy (CBT)
    Chronic neuropathic pain can be very distressing even when medicines help partly. CBT and pain self-management programs teach pacing, thought reframing, relaxation and distraction skills, and sleep hygiene. These approaches have good evidence across chronic pain conditions and are often recommended along with medication.ScienceDirect+2nhs.uk+2

16. Fatigue management and energy conservation
    Mitochondrial disease often causes severe fatigue that does not improve with rest. Occupational therapists teach “plan, pace, and prioritize,” breaking tasks into smaller steps, scheduling rest between activities, and using aids like wheeled carts or shower stools. This reduces over-exertion and protects limited energy.Wikipedia+2kennedykrieger.org+2

17. Monitoring spine and joints (orthopaedic follow-up)
    Scoliosis and hip or knee deformities may appear as weakness and imbalance progress. Regular review by orthopaedic teams allows early bracing, casting, or surgery when needed to keep sitting and standing easier. In CMT, scoliosis often needs surgery if curves progress despite bracing.PubMed+2Lippincott Journals+2

18. Sleep hygiene and treatment of sleep disorders
    Sleep problems, including restless legs, sleep apnoea, or insomnia, are common in neuromuscular and mitochondrial disease. Good sleep routines, careful use of sleep aids, and treatment of sleep apnoea with CPAP/BiPAP improve daytime function and mood.Wikipedia+2ScienceDirect+2

19. Vaccination and infection prevention
    Keeping up to date with vaccines (flu, pneumococcal, COVID-19 and others locally recommended) helps protect lungs and overall health. In mitochondrial disease, avoiding infections and fever spikes is important, because any stress can trigger regression or crises. Good hand hygiene and early treatment of infections are important preventive therapies.kennedykrieger.org+2mitochondrialdisease.nhs.uk+2

20. Regular specialist follow-up in a neuromuscular or mitochondrial clinic
    Because SURF1-related CMT is complex, follow-up in a specialist centre, when available, gives access to coordinated care, clinical trials, and updated genetic counselling. Natural-history studies of SURF1 deficiency show the disease course can be variable, so regular review helps adjust treatment over time.Springer+2ScienceDirect+2

---

Drug treatments

Again, no medicine currently cures SURF1-related CMT. Drugs are mainly used to relieve neuropathic pain, muscle stiffness, mood problems and sleep issues, similar to other CMT and neuropathies. Always follow your own doctor’s advice.

1. Pregabalin (Lyrica – gabapentinoid)
   Pregabalin is a nerve-pain and anti-seizure medicine. FDA labels show it is approved for neuropathic pain from diabetic neuropathy, post-herpetic neuralgia, spinal cord injury, fibromyalgia, and as add-on therapy for partial seizures. Typical adult neuropathic pain doses start at 150 mg/day in divided doses, increasing to 300–600 mg/day if tolerated. It calms over-active nerve signals by binding to calcium channels. Common side effects include dizziness, sleepiness, weight gain, and swelling. In CMT, doctors may use it off-label if neuropathic pain is significant.FDA Access Data+2FDA Access Data+2

2. Gabapentin (Neurontin – gabapentinoid)
   Gabapentin is another anti-seizure drug widely used for neuropathic pain, including post-herpetic neuralgia and other nerve pains. Labels and reviews show gabapentin reduces pain responses in many neuropathic pain models and is approved in several countries for PHN. Doses often start at 300 mg at night and are slowly increased to 900–1800 mg/day or more, depending on kidney function. Side effects include sleepiness, dizziness, and swelling, so slow titration is important.FDA Access Data+1

3. Duloxetine (Cymbalta – SNRI antidepressant)
   Duloxetine is an antidepressant that also treats neuropathic pain. The FDA label shows it is approved for diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain, at 60 mg once daily in adults. It works by increasing serotonin and noradrenaline in pain pathways. Side effects can include nausea, dry mouth, sleepiness or insomnia, and raised blood pressure; it must not be stopped suddenly. In CMT, doctors may use duloxetine off-label in adults with significant nerve pain and low mood.FDA Access Data+2FDA Access Data+2

4. Amitriptyline (tricyclic antidepressant)
   Amitriptyline is an older antidepressant often used in low doses for neuropathic pain and sleep. Typical adult starting doses are 10–25 mg at bedtime, slowly increased as needed. It blocks reuptake of serotonin and noradrenaline and also blocks some pain-related receptors. Common side effects are dry mouth, constipation, weight gain, and drowsiness; it can also affect heart rhythm at higher doses or in people with heart disease, so monitoring is needed.ScienceDirect+2nhs.uk+2

5. Nortriptyline (tricyclic antidepressant)
   Nortriptyline is similar to amitriptyline but may be slightly better tolerated, with less sedation for some people. It is also widely used for neuropathic pain in general practice, usually at 10–25 mg at night and titrated upward. Mechanism and side effects are similar to amitriptyline, with anticholinergic effects and cardiac risks at higher doses, so ECG monitoring may be needed in older adults.ScienceDirect+2nhs.uk+2

6. Topical lidocaine 5% patch (Lidoderm, ZTlido)
   Lidocaine patches slowly release a local anaesthetic through the skin. FDA labels show they are approved for pain from post-herpetic neuralgia but are often used off-label for other localized neuropathic pains. Patches are usually applied up to 12 hours on, 12 hours off on intact skin. They work by blocking sodium channels in nerve endings, reducing abnormal firing. Side effects are usually mild skin irritation; serious toxicity occurs mainly if too many patches are used.FDA Access Data+2FDA Access Data+2

7. Topical capsaicin 8% patch (Qutenza)
   Qutenza contains high-strength capsaicin, a chili-pepper compound that overstimulates then “switches off” pain-carrying nerve endings for weeks. FDA documents show it is approved for neuropathic pain from post-herpetic neuralgia and diabetic neuropathy of the feet in adults, applied in clinic for 30–60 minutes every few months. During application it can cause burning pain, so local anaesthetic and monitoring are needed. It is not a first-line treatment but may be tried in highly localized, severe neuropathic pain.FDA Access Data+2FDA Access Data+2

8. Tramadol (weak opioid and monoamine reuptake inhibitor)
   Tramadol is a centrally acting painkiller sometimes used for short-term or breakthrough neuropathic pain when first-line agents are not enough. It acts on opioid receptors and also increases serotonin and noradrenaline. Typical adult doses are 50–100 mg up to 4 times daily, but dependence, dizziness, nausea, and risk of serotonin syndrome must be considered, especially if combined with antidepressants. Many guidelines now limit tramadol to short-term use under close supervision.ScienceDirect+1

9. Baclofen (muscle relaxant for spasticity)
   Baclofen acts on GABA-B receptors in the spinal cord to reduce excessive muscle tone. It is widely used for spasticity in conditions like cerebral palsy and spinal cord injury. In some CMT or mitochondrial patients with central involvement and spasticity, baclofen may help, usually starting at 5 mg three times a day and increasing as needed. Side effects include sleepiness, weakness, and dizziness; sudden withdrawal can cause seizures and hallucinations, so it must be tapered slowly.PMC+2The Open Neurology Journal+2

10. Tizanidine (alpha-2 agonist muscle relaxant)
    Tizanidine reduces spasticity by blocking excitatory nerve signals in the spinal cord. It is used for spasticity in multiple sclerosis and spinal cord disease and may be used off-label in other neuromuscular conditions with central tone problems. Typical adult doses start at 2–4 mg up to three times daily, but liver function must be monitored. Common side effects are sedation, dry mouth, and low blood pressure.PMC+2The Open Neurology Journal+2

11. NSAIDs and paracetamol (for background musculoskeletal pain)
    Simple painkillers like paracetamol (acetaminophen) and non-steroidal drugs (ibuprofen, naproxen) do not treat neuropathic pain well, but they help with joint and muscle pain due to deformity, overuse, or surgery. Doses must respect national guidelines to avoid liver, stomach, and kidney damage. They are often combined with neuropathic pain medicines to address both “nerve” and “mechanical” components of pain.ScienceDirect+2Medscape+2

12. Medicines for mood, sleep, and anxiety (SSRIs, SNRIs, melatonin and others)
    Long-term disability often leads to depression, anxiety, and sleep problems. Standard antidepressants (SSRIs/SNRIs) and safe sleep aids may be used according to general psychiatric guidelines. Treating mood is not “cosmetic”; studies across chronic neurological diseases show that better mood strongly improves quality of life and adherence to rehabilitation.nhs.uk+2Wikipedia+2

Because this disease is rare, all drug choices are individual and off-label. A paediatric neurologist or adult neuromuscular specialist must review all medicines regularly.

---

Dietary molecular supplements

There is no single proven supplement that stops SURF1-related CMT. Many centres use a “mitochondrial cocktail” of vitamins and cofactors with the hope of supporting energy pathways. Evidence is mixed, and benefits may be modest or absent in some patients, but these options are often considered on a case-by-case basis.

1. Coenzyme Q10 (ubiquinone)
   CoQ10 is a key molecule in the mitochondrial respiratory chain. Reviews show that CoQ10 can help some patients with primary CoQ10 deficiency and may give modest benefit in some mitochondrial respiratory chain disorders and neuropathies by improving electron transport and acting as an antioxidant. Typical adult doses range from 100–300 mg/day or higher, divided with meals containing fat. Side effects are usually mild (stomach upset, headache).Exploration Publishing+3SAGE Journals+3ScienceDirect+3

2. L-carnitine or acetyl-L-carnitine
   Carnitine moves long-chain fatty acids into mitochondria for energy and helps remove toxic acyl groups. Studies show L-carnitine can support mitochondrial function and may improve exercise tolerance in some mitochondrial myopathies and older adults. Doses often range from 500–2000 mg/day, divided. Side effects include fishy body odour or diarrhoea. In theory, better fat use may support nerve and muscle cells.European Society of Medicine –+3PMC+3PMC+3

3. Riboflavin (vitamin B2)
   Riboflavin is a precursor of FAD and FMN, co-factors for many mitochondrial enzymes. Riboflavin-responsive neuropathies and mitochondrial disorders have been described, where high-dose B2 improved or stabilised symptoms. Doses in such conditions can be 50–400 mg/day, but in rare mitochondrial disease they must be guided by a specialist. It is usually well tolerated, turning urine bright yellow.Ovid+3PMC+3PMC+3

4. Thiamine (vitamin B1)
   Thiamine is vital for carbohydrate metabolism and mitochondrial energy production. Deficiency can cause neuropathy and cardiomyopathy; supplementation helps deficiency states and some genetic conditions. In mitochondrial practice, doses of 50–300 mg/day may be used, but evidence for benefit in SURF1-related disease is limited.kennedykrieger.org+1

5. Alpha-lipoic acid (ALA)
   Alpha-lipoic acid is an antioxidant and mitochondrial cofactor. Trials in diabetic neuropathy show that oral or intravenous ALA can reduce neuropathic pain and improve some nerve function scores, often at 600 mg/day. It may reduce oxidative stress and improve endoneural blood flow. Side effects can include stomach upset and rarely hypoglycaemia. Its use in CMT is off-label and experimental.Cochrane Library+3PubMed+3MDPI+3

6. Vitamin C and vitamin E (antioxidants)
   These vitamins help neutralise free radicals and are sometimes included in mitochondrial cocktails to reduce oxidative stress. Evidence is limited and mixed, but they are generally safe at moderate doses. High-dose vitamin E can increase bleeding risk and vitamin C can cause kidney stones in susceptible people, so doses should be guided by a clinician.kennedykrieger.org+2PMC+2

7. Vitamin D and calcium
   Weak muscles, low activity, and steroid use can weaken bones. Adequate vitamin D and calcium support bone health and reduce fracture risk. Many guidelines recommend checking vitamin D levels in chronic neuromuscular diseases and supplementing if low, with doses depending on blood results and local guidelines.European Review+2Charcot-Marie-Tooth Association+2

8. Omega-3 fatty acids (EPA/DHA)
   Omega-3 fats from fish oil may have anti-inflammatory and neuroprotective effects and can support heart and vascular health. Some studies in neuropathy suggest symptom improvement, though evidence is not strong. Typical doses are 1–3 g/day combined EPA/DHA, but they may thin the blood at higher doses.e-DMJ+2Spandidos Publications+2

9. B-complex vitamins (B6, B12, folate)
   B6, B12 and folate are important for nerve function and homocysteine metabolism. Deficiency can cause neuropathy, so screening and correcting low levels is important. Doses vary, but B12 is often given as high-dose oral or injections in deficiency states. Too much B6 can itself cause neuropathy, so supplementation should be monitored.PMC+1

10. Magnesium and trace elements (e.g., selenium)
    These minerals help many enzymes and can support muscle relaxation and antioxidant defence. Deficiency is common in chronic illness or with poor intake. Supplementation is usually modest and tailored after blood tests. High doses of magnesium can cause diarrhoea; selenium excess can be toxic, so medical supervision is needed.European Review+2kennedykrieger.org+2

---

Immunity-booster, regenerative and stem-cell-related therapies

At present, there are no approved stem-cell or gene-therapy drugs for SURF1-related CMT, but research is active in many mitochondrial and neuropathic disorders. The options below are experimental concepts, not standard treatments.

1. Mitochondrial “cocktail” as functional support
   Combining CoQ10, carnitine, riboflavin, and antioxidants is widely used as a “functional regenerative” support, with the aim of improving mitochondrial biogenesis and protecting cells from oxidative stress. Reviews highlight that evidence is limited and variable, and effects are often modest, but some patients report better endurance and fewer crises.ScienceDirect+1

2. Alpha-lipoic acid plus carnitine combinations
   Studies in ageing and mitochondrial injury models suggest that combining ALA and carnitine can improve mitochondrial membrane potential, gene expression, and biogenesis, acting as a functional “booster” for stressed cells. These findings are mostly from animal and experimental models, so translation to SURF1 CMT remains uncertain, but they support the idea of combined mitochondrial-targeted therapy under specialist guidance.Springer+2PNAS+2

3. Gene therapy targeting SURF1 (preclinical/early research)
   Because SURF1 is a single nuclear gene, it is theoretically a good candidate for gene replacement using viral vectors. Preclinical studies in other mitochondrial genes and early gene therapy successes in neuromuscular disorders (like spinal muscular atrophy) encourage active research. For SURF1, only early natural-history and mechanistic work is published so far; any gene therapy would currently be available only in carefully controlled clinical trials.Springer+2Children’s Hospital of Philadelphia+2

4. Cell-based or stem-cell therapies for neuropathy (experimental)
   Mesenchymal stem cells and other cell therapies are being studied in various neuropathies and neurodegenerative diseases, aiming to release growth factors, reduce inflammation, and support nerve repair. So far, results are preliminary and not specific to SURF1-related disease, and long-term safety is not yet proven. International guidelines advise that patients avoid unregulated “stem-cell clinics” and only join ethical clinical trials.ScienceDirect+1

5. Immune-modulating therapies in selected cases
   If a person with SURF1-related CMT also shows features of autoimmune neuropathy (for example, acute worsening with inflammatory markers), treatments such as intravenous immunoglobulin (IVIG) or steroids may be considered. These are standard for inflammatory neuropathies like CIDP, but not for pure genetic CMT. Their use must be guided by careful diagnostic work-up.ERS Publications+2ScienceDirect+2

6. Future small-molecule mitochondrial modulators
   Many studies are developing drugs that enhance mitochondrial biogenesis, improve mitophagy, or reduce oxidative damage. Some target pathways like PGC-1α and Nrf2, which regulate mitochondrial growth and antioxidant defences. These agents are still in early phases but may in future offer disease-modifying options for mitochondrial neuropathies.Spandidos Publications+2Institute for Functional Medicine+2

---

Surgeries and procedures

Surgery does not treat the nerve damage but can correct deformities and make standing, walking, and caring for the person easier.

1. Foot deformity surgery (tendon transfers, osteotomies, soft-tissue release)
   In CMT, high-arched (cavovarus) feet, claw toes, and ankle instability are common. Surgeons can transfer tendons, cut and realign bones (osteotomies), and lengthen tight soft tissues to restore balance and reduce deforming forces. Studies show that such surgery, when done early enough, can improve walking, reduce pain, and delay joint arthritis.Ovid+3PubMed+3Charcot-Marie-Tooth Association+3

2. Joint fusion procedures (e.g., triple arthrodesis)
   When foot deformities become severe and fixed, fusing some foot joints can give a more stable, plantigrade foot for standing and walking, even though some movement is lost. This can reduce pain, improve shoe wear, and prevent recurrent ulcers. It is usually reserved for advanced cases after bracing and softer tissue surgery are no longer enough.Charcot-Marie-Tooth Disease+2Foot & Ankle Surgery+2

3. Spinal surgery for scoliosis
   Some people with severe CMT develop scoliosis with thoracic hyperkyphosis. Bracing often fails; in such cases, long posterior spinal fusion with rods and screws can straighten and stabilise the spine and improve sitting balance and lung function. Studies report acceptable complication rates when done in experienced centres.PubMed+2Lippincott Journals+2

4. Nerve decompression surgeries (e.g., carpal tunnel release)
   CMT makes nerves more vulnerable to pressure. Super-added entrapment neuropathies, such as carpal tunnel syndrome, can cause extra weakness and pain in the hands. Releasing the compressed nerve surgically can relieve symptoms, though it does not change the underlying CMT.Medscape+2ScienceDirect+2

5. Feeding tubes or tracheostomy in advanced disease
   In some severe mitochondrial conditions, swallowing and breathing muscles become too weak to keep up. A gastrostomy tube can provide safe nutrition and medicines, while tracheostomy with ventilation can support breathing and comfort. Case reports in mitochondrial disease show that when carefully planned, these procedures can improve quality of life rather than shorten it.ERS Publications+3Muscular Dystrophy Association+3PMC+3

---

Prevention and protection strategies

We cannot yet prevent the genetic mutation, but we can reduce complications:

1. Avoid falls with braces, aids, and home safety changes.orthobullets.com+2Charcot-Marie-Tooth Association+2

2. Maintain a healthy weight to reduce stress on weak feet, ankles, and knees.Charcot-Marie-Tooth News+2European CMT Federation+2

3. Avoid prolonged fasting, dehydration, and severe infections, which stress mitochondria; seek early treatment for fevers and stomach illnesses.mitochondrialdisease.nhs.uk+2kennedykrieger.org+2

4. Stay up-to-date with vaccines to reduce lung infections.kennedykrieger.org+2mitochondrialdisease.nhs.uk+2

5. Do regular, gentle exercise to hold onto strength as much as possible without over-exercising.nhs.uk+2PubMed+2

6. Use ankle-foot orthoses and good shoes early, not only when deformity is severe.ScienceDirect+2ENMC+2

7. Protect feet and skin – daily checks, good hygiene, and podiatry to prevent ulcers and infections.Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth News+2

8. Avoid unproven “stem-cell” or miracle therapies outside registered clinical trials.ScienceDirect+1

9. Join a neuromuscular or mitochondrial registry or natural-history study if offered, to gain earlier access to new treatments and improve knowledge.Springer+2PMC+2

10. Support mental health, as good coping reduces secondary problems like poor sleep, inactivity, and social isolation.FDA Access Data+2Charcot-Marie-Tooth Association+2

---

When to see a doctor urgently

For SURF1-related CMT and mitochondrial disease, you should get urgent medical help if you notice:

• Sudden or fast-worsening weakness, especially if walking or hand function quickly changes.Springer+2The Open Neurology Journal+2

• New breathing problems, such as shortness of breath at rest, morning headaches, or disturbed sleep with gasping or pauses.The Open Neurology Journal+2journal.chestnet.org+2

• Choking, frequent chest infections, or big change in swallowing.ERS Publications+2mitoaction.org+2

• High fever, vomiting, or not being able to drink and eat for many hours, especially in children with mitochondrial disease.mitochondrialdisease.nhs.uk+2European Review+2

• New seizures, confusion, severe headaches, or changes in vision or eye movements.Springer+2Children’s Hospital of Philadelphia+2

• Severe or rapidly increasing pain that is not helped by usual medicines.ScienceDirect+2nhs.uk+2

Regular planned visits with your neuromuscular team (often every 6–12 months) are also important, even when things feel stable.

---

What to eat and what to avoid

There is no specific “CMT diet,” but general mitochondrial-friendly and CMT-friendly patterns are suggested:

Helpful to eat more of:

1. Regular balanced meals and snacks with enough calories to avoid fasting and energy crashes, especially in children.mitoaction.org+2mitocanada.org+2

2. Plenty of fruits and vegetables, which provide vitamins, minerals, and antioxidants that support general cellular health.Charcot-Marie-Tooth News+2European CMT Federation+2

3. Lean proteins such as fish, poultry, beans, and pulses support muscle repair and immune function.Charcot-Marie-Tooth News+2European CMT Federation+2

4. Whole-grain carbohydrates (whole-grain bread, brown rice, oats) for steady energy rather than sugar spikes and drops.Charcot-Marie-Tooth News+2European CMT Federation+2

5. Healthy fats (olive oil, nuts, seeds, avocado) that support cell membranes and brain function and are easier to use for slow energy.Spandidos Publications+2Charcot-Marie-Tooth Association+2

Useful to limit or avoid:

6. Very high sugar foods and drinks (sweets, sodas) that cause rapid blood sugar swings and may worsen fatigue and weight gain.Charcot-Marie-Tooth News+2European CMT Federation+2

7. Very fatty, greasy fast food, which can slow stomach emptying and may worsen gut symptoms and weight gain.mitoaction.org+2European Review+2

8. Excessive caffeine and energy drinks, which disturb sleep and can increase palpitations or anxiety.Charcot-Marie-Tooth News+2Wikipedia+2

9. Long periods without food or fluids, especially during illness; these increase metabolic stress in mitochondrial disease.mitochondrialdisease.nhs.uk+2mitocanada.org+2

10. Alcohol and tobacco, which can damage nerves, muscles, and mitochondria further and interact with medicines.Spandidos Publications+2Wikipedia+2

A dietitian with mitochondrial and neuromuscular experience can create a personalised plan.

---

Frequently asked questions (FAQs)

1. Is there any cure for SURF1-related severe demyelinating CMT?
No cure is available yet. Current treatments are supportive and focus on symptoms, maintaining function, and preventing complications. Research into gene therapy and better mitochondrial drugs is active but still at early stages.Springer+2ScienceDirect+2

2. Will physiotherapy make the disease progress faster?
Well-planned, low-impact physiotherapy is not known to speed nerve damage and generally helps maintain strength, flexibility, and function in CMT. Over-exertion that causes long-lasting pain or exhaustion should be avoided, but moderate exercise has shown benefits in trials.nhs.uk+2PubMed+2

3. Can supplements like CoQ10 or carnitine stop the disease?
Supplements may modestly support mitochondrial function in some people, but evidence that they fully stop or reverse disease is limited and mixed. They should be seen as supportive, not curative, and used under specialist monitoring.SAGE Journals+2ScienceDirect+2

4. Are pain medicines like pregabalin or duloxetine safe long term?
These medicines are widely used long term for chronic neuropathic pain in other conditions. They can help many people, but they also have side effects (like dizziness, weight gain, sleepiness, mood changes) and must be regularly reviewed. Dose changes or switches are common.FDA Access Data+3FDA Access Data+3FDA Access Data+3

5. Is surgery always needed for foot deformities?
No. Many people do well for years with braces, shoe adjustments, and physiotherapy. Surgery is usually considered when deformity causes pain, recurrent ulcers, or major instability that cannot be managed with conservative measures. Decisions are individual and based on age, deformity, and goals.Charcot-Marie-Tooth Association+2ENMC+2

6. Will my breathing definitely fail because it is a mitochondrial disease?
Not everyone with SURF1-related disease develops severe breathing failure, but risk can be higher than in some other CMT types. Regular lung checks, sleep studies, and early use of non-invasive ventilation when needed can greatly reduce complications.The Open Neurology Journal+2PMC+2

7. Can diet alone treat this condition?
No diet can repair the gene change or fully stop nerve damage. However, a good mitochondrial-friendly diet, avoiding fasting, and supporting healthy weight can make daily life easier and reduce complications like obesity and diabetes, which would further harm nerves and joints.kennedykrieger.org+3Charcot-Marie-Tooth News+3mitocanada.org+3

8. Is it safe to become pregnant if I have SURF1-related CMT?
Pregnancy is possible for many people with CMT, but mitochondrial disease can add risks such as fatigue, respiratory strain, or metabolic crises. Pre-pregnancy counselling with genetics, neurology, and obstetrics teams is essential to discuss risks and monitoring.Springer+2kennedykrieger.org+2

9. Can children with this disease go to regular school?
Many children can attend regular school with support such as physical access, extra time for tasks, and aids for writing. An individual education plan with input from therapists and teachers helps match demands to ability and energy.Charcot-Marie-Tooth Association+2European CMT Federation+2

10. Should I join clinical trials?
If a reputable clinical trial is available, joining can give access to new therapies and helps improve knowledge for future patients. However, trials may involve risks and extra hospital visits. It is important to discuss benefits and risks with your specialist team before deciding.Springer+1

11. Can intermittent fasting or ketogenic diets help mitochondrial health here?
Some research shows fasting or ketogenic diets can influence mitochondrial function in obesity and other conditions, but in many mitochondrial diseases, prolonged fasting is risky and generally discouraged, especially in children. Any special diet should only be tried under expert supervision.kennedykrieger.org+3Institute for Functional Medicine+3ScienceDirect+3

12. Do vaccines worsen mitochondrial or CMT symptoms?
There is no strong evidence that routine vaccines worsen CMT or mitochondrial disease. In fact, infections can be much more dangerous, so most expert centres encourage full vaccination, sometimes with special monitoring. Specific plans should be set with your own doctors.kennedykrieger.org+2mitochondrialdisease.nhs.uk+2

13. Could another child in the family have the same disease?
Because SURF1-related CMT is usually autosomal recessive, each full sibling has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being neither, if both parents are carriers. Genetic testing and counselling help clarify this for your family.ZFIN+2Springer+2

14. Is it worth doing exercise if I already use a wheelchair?
Yes. Even if leg muscles are very weak, exercises for arms, trunk, breathing muscles, and remaining leg muscles can improve comfort, circulation, and mood. Therapists can design wheelchair-based exercise and gentle strength and flexibility programmes.PubMed+2nhs.uk+2

15. Where can families find more support?
National and international organisations for Charcot-Marie-Tooth and mitochondrial diseases offer education, peer support, and often help to connect with specialist centres. Examples include CMT associations and mitochondrial disease foundations in many countries. Your neurologist or genetic counsellor can help identify trusted groups.Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth News+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 31, 2025.